The Sialomucin CD34 Is a Marker of Lymphatic Endothelial Cells in Human Tumors
- 31 March 2006
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 168 (3) , 1045-1053
- https://doi.org/10.2353/ajpath.2006.050554
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Up-Regulation of the Lymphatic Marker Podoplanin, a Mucin-Type Transmembrane Glycoprotein, in Human Squamous Cell Carcinomas and Germ Cell TumorsThe American Journal of Pathology, 2005
- Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammationTrends in Immunology, 2004
- Preexisting Lymphatic Endothelium but not Endothelial Progenitor Cells Are Essential for Tumor Lymphangiogenesis and Lymphatic MetastasisCancer Research, 2004
- Lymphangiogenesis and tumor metastasisCell and tissue research, 2003
- VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cellsBlood, 2003
- Lymphangiogenesis and cancer metastasisNature Reviews Cancer, 2002
- The role of tumor lymphangiogenesis in metastatic spreadThe FASEB Journal, 2002
- Molecular Cloning and Characterization of Endosialin, a C-type Lectin-like Cell Surface Receptor of Tumor EndotheliumJournal of Biological Chemistry, 2001
- Genes Expressed in Human Tumor EndotheliumScience, 2000
- Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic CapillariesThe American Journal of Pathology, 1999